Market closed
The Oncology Institute Inc./$TOI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Ticker
$TOI
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
825
Website
TOI Metrics
BasicAdvanced
$109M
-
-$0.71
0.24
-
Price and volume
Market cap
$109M
Beta
0.24
52-week high
$1.59
52-week low
$0.60
Financial strength
Current ratio
2.153
Quick ratio
1.884
Long term debt to equity
3,241.962
Total debt to equity
3,431.374
Interest coverage (TTM)
-8.02%
Management effectiveness
Return on assets (TTM)
-19.67%
Return on equity (TTM)
-213.36%
Valuation
Price to revenue (TTM)
0.275
Price to book
30.39
Price to tangible book (TTM)
-5.91
Price to free cash flow (TTM)
-3.563
Growth
Revenue change (TTM)
21.33%
Earnings per share change (TTM)
-23.26%
3-year revenue growth (CAGR)
24.68%
3-year earnings per share growth (CAGR)
63.88%
TOI News
AllArticlesVideos
The Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call Transcript
Seeking Alpha·2 weeks ago
The Oncology Institute Announces $16.5 million Private Placement
GlobeNewsWire·2 weeks ago
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for The Oncology Institute Inc. stock?
The Oncology Institute Inc. (TOI) has a market cap of $109M as of April 05, 2025.
What is the P/E ratio for The Oncology Institute Inc. stock?
The price to earnings (P/E) ratio for The Oncology Institute Inc. (TOI) stock is 0 as of April 05, 2025.
Does The Oncology Institute Inc. stock pay dividends?
No, The Oncology Institute Inc. (TOI) stock does not pay dividends to its shareholders as of April 05, 2025.
When is the next The Oncology Institute Inc. dividend payment date?
The Oncology Institute Inc. (TOI) stock does not pay dividends to its shareholders.
What is the beta indicator for The Oncology Institute Inc.?
The Oncology Institute Inc. (TOI) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.